Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Colonoscopy and sigmoidoscopy provide protection against colorectal cancer, but the magnitude and duration of protection, particularly against cancer of the proximal colon, remain uncertain. METHODS: We examined the association of the use of lower endoscopy (updated biennially from 1988 through 2008) with colorectal-cancer incidence (through June 2010) and colorectal-cancer mortality (through June 2012) among participants in the Nurses' Health Study and the Health Professionals Follow-up Study. RESULTS: Among 88,902 participants followed over a period of 22 years, we documented 1815 incident colorectal cancers and 474 deaths from colorectal cancer. With endoscopy as compared with no endoscopy, multivariate hazard ratios for colorectal cancer were 0.57 (95% confidence interval [CI], 0.45 to 0.72) after polypectomy, 0.60 (95% CI, 0.53 to 0.68) after negative sigmoidoscopy, and 0.44 (95% CI, 0.38 to 0.52) after negative colonoscopy. Negative colonoscopy was associated with a reduced incidence of proximal colon cancer (multivariate hazard ratio, 0.73; 95% CI, 0.57 to 0.92). Multivariate hazard ratios for death from colorectal cancer were 0.59 (95% CI, 0.45 to 0.76) after screening sigmoidoscopy and 0.32 (95% CI, 0.24 to 0.45) after screening colonoscopy. Reduced mortality from proximal colon cancer was observed after screening colonoscopy (multivariate hazard ratio, 0.47; 95% CI, 0.29 to 0.76) but not after sigmoidoscopy. As compared with colorectal cancers diagnosed in patients more than 5 years after colonoscopy or without any prior endoscopy, those diagnosed in patients within 5 years after colonoscopy were more likely to be characterized by the CpG island methylator phenotype (CIMP) (multivariate odds ratio, 2.19; 95% CI, 1.14 to 4.21) and microsatellite instability (multivariate odds ratio, 2.10; 95% CI, 1.10 to 4.02). CONCLUSIONS: Colonoscopy and sigmoidoscopy were associated with a reduced incidence of cancer of the distal colorectum; colonoscopy was also associated with a modest reduction in the incidence of proximal colon cancer. Screening colonoscopy and sigmoidoscopy were associated with reduced colorectal-cancer mortality; only colonoscopy was associated with reduced mortality from proximal colon cancer. Colorectal cancer diagnosed within 5 years after colonoscopy was more likely than cancer diagnosed after that period or without prior endoscopy to have CIMP and microsatellite instability. (Funded by the National Institutes of Health and others.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A prospective cohort study involving 89000 healthcare workers over 24 years concluded that systematic use of colonoscopy for screening results in a 68% reduction in CRC mortality compared to individuals without CRC screening[66].”
From Risk factors, prevention and screening of colorectal cancer: A rising problem (2025) · cites this paper as [66]
In the citing paper
“Every 1% rise in ADR will lead to a 3% reduction in the risk of interval colorectal cancer [9].”
From Advancing Colorectal Cancer Screening: A Comprehensive Systematic Review of Artificial Intelligence (AI)-Assisted Versus Routine Colonoscopy (2023) · cites this paper as [9]
Citations
Cites
Prevention of Colorectal Cancer by Colonoscopic Polypectomy
Winawer, S. J., Zauber, A. G., Ho, M. N., O'Brien, M. J., Gottlieb, L. S., Sternberg, S. S., Waye, J. D., Schapiro, M., Bond, J. H., Panish, J. F., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292701 · Cited by 4,592
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
Zauber, A. G., Winawer, S. J., O'Brien, M. J., Lansdorp-Vogelaar, I., van Ballegooijen, M., Hankey, B. F., Shi, W., Bond, J. H., Schapiro, M., Panish, J. F., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1100370 · Cited by 3,185
Levin, B., Lieberman, D. A., McFarland, B., Andrews, K. S., Brooks, D., Bond, J., Dash, C., Giardiello, F. M., Glick, S., Johnson, D., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.002 · Cited by 2,990
Quality Indicators for Colonoscopy and the Risk of Interval Cancer
Kaminski, M. F., Regula, J., Kraszewska, E., Polkowski, M., Wojciechowska, U., Didkowska, J., Zwierko, M., Rupinski, M., Nowacki, M. P., & Butruk, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907667 · Cited by 2,010
Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-9-200811040-00243 · Cited by 1,959
Lieberman, D. A., Rex, D. K., Winawer, S. J., Giardiello, F. M., Johnson, D. A., & Levin, T. R. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.001 · Cited by 1,892
Levin, B., Lieberman, D. A., McFarland, B., Smith, R. A., Brooks, D., Andrews, K. S., Dash, C., Giardiello, F. M., Glick, S., Levin, T. R., et al. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0018 · Cited by 1,801
Atkin, W. S., Edwards, R., Kralj-Hans, I., Wooldrage, K., Hart, A. R., Northover, J. M., Parkin, D. M., Wardle, J., Duffy, S. W., & Cuzick, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60551-x · Cited by 1,623
American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008
Rex, D. K., Johnson, D. A., Anderson, J. C., Schoenfeld, P. S., Burke, C. A., & Inadomi, J. M. (2009) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.104 · Cited by 1,401
Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps
Maisonneuve, P., Botteri, E., & Lowenfels, A. B. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.039 · Cited by 1,183
Cited by
Items 101–200 of 1,000
Population-based screening for cancer: hope and hype
Shieh, Y., Eklund, M., Sawaya, G. F., Black, W. C., Kramer, B. S., & Esserman, L. J. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.50 · Cited by 166
Cost-Effectiveness of Colorectal Cancer Screening Strategies—A Systematic Review
Ran, T., Cheng, C.-Y., Misselwitz, B., Brenner, H., Ubels, J., & Schlander, M. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.01.014 · Cited by 139
van Hattem, W. A., Shahidi, N. C., Vosko, S., Hartley, I., Britto, K., Sidhu, M., Bar-Yishay, I., Schoeman, S., Tate, D. J., Byth, K., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-321753 · Cited by 158
García-Albéniz, X., Hsu, J., Bretthauer, M., & Hernán, M. A. (2017) · Annals of Internal Medicine · doi:10.7326/m16-0758 · Cited by 142
Andersen, S. W., Blot, W. J., Lipworth, L. P., Steinwandel, M. D., Murff, H. J., & Zheng, W. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.17995 · Cited by 148
Cause, Epidemiology, and Histology of Polyps and Pathways to Colorectal Cancer
Sullivan, B. A., Noujaim, M. G., & Roper, J. (2022) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2021.12.001 · Cited by 175
Molecular markers for colorectal cancer screening
Dickinson, B., Kisiel, J. B., Ahlquist, D. A., & Grady, W. M. (2015) · Gut · doi:10.1136/gutjnl-2014-308075 · Cited by 157
Colorectal cancer deaths attributable to nonuse of screening in the United States
Meester, R. G. S., Doubeni, C. A., Lansdorp‐Vogelaar, I., Goede, S. L., Levin, T. R., Quinn, V. P., van Ballegooijen, M., Corley, D. A., & Zauber, A. G. (2014) · Annals of Epidemiology · doi:10.1016/j.annepidem.2014.11.011 · Cited by 152
“32 recently reported for a prospective cohort study with 22 years of follow-up [33].”
BackgroundMethodSerrated lesions in colorectal cancer screening: detection, resection, pathology and surveillance
East, J. E., Vieth, M., & Rex, D. K. (2015) · Gut · doi:10.1136/gutjnl-2014-309041 · Cited by 138
“However, colonoscopy is not as effective in colorectal cancer prevention in the right colon as in the left[3-5].”
BackgroundBrenner, H., Altenhofen, L., Kretschmann, J., Rösch, T., Pox, C. P., Stock, C., & Hoffmeister, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.012 · Cited by 147
A Model to Determine Colorectal Cancer Risk Using Common Genetic Susceptibility Loci
Hsu, L., Jeon, J., Brenner, H., Gruber, S. B., Schoen, R. E., Berndt, S. I., Chan, A. T., Chang-Claude, J. C., Du, M., Gong, J., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.02.010 · Cited by 151
Self-citationEvaluation of Colorectal Cancer Incidence Trends in the United States (2000–2014)
Ansa, B. E., Coughlin, S. S., Alema‐Mensah, E., & Smith, S. A. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7020022 · Cited by 135
Molecular phenotypes of colorectal cancer and potential clinical applications
Kocarnik, J. M., Shiovitz, S., & Phipps, A. I. (2015) · Gastroenterology Report · doi:10.1093/gastro/gov046 · Cited by 132
Ananthakrishnan, A. N., Cagan, A., Cai, T., Gainer, V. S., Shaw, S. Y., Churchill, S., Karlson, E. W., Murphy, S. N., Kohane, I., & Liao, K. P. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.07.018 · Cited by 131
Race, Ethnicity, and Sex Affect Risk for Polyps >9 mm in Average-Risk Individuals
Lieberman, D. A., Williams, J. L., Holub, J. L., Morris, C. D., Logan, J. R., Eisen, G. M., & Carney, P. A. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.04.037 · Cited by 130
Atkin, W., Cross, A. J., Kralj-Hans, I., MacRae, E., Piggott, C., Pearson, S., Wooldrage, K., Brown, J., Lucas, F., Prendergast, A., et al. (2019) · Health Technology Assessment · doi:10.3310/hta23010 · Cited by 129
Krabbamein í ristli og endaþarmi - yfirlitsgrein
Haraldsdóttir, S., Einarsdóttir, H. M., Smáradóttir, A., Gunnlaugsson, A., Halfdanarson, T. R., & Hálfdánarson, Þ. R. (2014) · Læknablaðið · doi:10.17992/lbl.2014.02.531 · Cited by 146
Floer, M., Biecker, E., Fitzlaff, R., Röming, H., Ameis, D., Heinecke, A., Kunsch, S., Ellenrieder, V., Ströbel, P., Schepke, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114267 · Cited by 129
“, it could be shown that endoscopic removal of polyps was associated with reduced incidences of colorectal cancer mortality [1].”
BackgroundEarly-onset colorectal cancer: A sporadic or inherited disease?
Stigliano, V., Sanchez-Mete, L., Martayan, A., & Anti, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i35.12420 · Cited by 147
Interval colorectal cancer after colonoscopy: exploring explanations and solutions
Adler, J., & Robertson, D. J. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.365 · Cited by 129
Holme, Ø., Schoen, R. E., Senore, C., Segnan, N., Hoff, G., Løberg, M., Bretthauer, M., Adami, H.-O., & Kalager, M. (2017) · BMJ · doi:10.1136/bmj.i6673 · Cited by 130
Hamada, T., Cao, Y., Qian, Z. R., Masugi, Y., Nowak, J. A., Yang, J., Song, M., Mima, K., Kosumi, K., Liu, L., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.7547 · Cited by 129
Self-citationCarr, P. R., Weigl, K., Edelmann, D., Jansen, L., Chang-Claude, J., Brenner, H., & Hoffmeister, M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.03.016 · Cited by 119
“No colonoscopy Low genetic risk Unfavorable lifestyle 164 (40)/88 (26) Intermediate lifestyle 157 (38)/123 (36) Favorable lifestyle 87 (21)/134 (39) Intermediate genetic risk Unfavorable lifestyle 260 (41)/97 (30) Intermediate lifestyle 216 (34)/120 (37) Favorable lifestyle 153 (24)/108 (33) High genetic risk Unfavora…”
BackgroundKamba, S., Tamai, N., Saitoh, I., Matsui, H., Horiuchi, H., Kobayashi, M., Sakamoto, T., Ego, M., Fukuda, A., Tonouchi, A., et al. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-021-01808-w · Cited by 124
Carethers, J. M. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3443-5 · Cited by 122
“Sigmoidoscopy offered no protection from mortality in the right colon, whereas patients post-colonoscopy showed a 53 % reduction in death from proximal cancers [66].”
Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA
Chen, X., Zhao, D., Hubbell, E. A., Kurtzman, K. N., Oxnard, G. R., Venn, O., Melton, C. A., Clarke, C. A., Shaknovich, R., Ma, T., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0417 · Cited by 128
“Existing single-cancer screening tests for early cancer detection improve survival (20, 38), but may still contribute to overdiagnosis.”
Screening for Colorectal Neoplasia
Inadomi, J. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmcp1512286 · Cited by 119
Doubeni, C. A., Fedewa, S. A., Levin, T. R., Jensen, C. D., Saia, C. A., Zebrowski, A. M., Quinn, V. P., Rendle, K. A. S., Zauber, A. G., Becerra-Culqui, T. A., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.09.040 · Cited by 131
Colorectal Cancer in African Americans: An Update
Williams, R., White, P. M., Nieto, J. M., Vieira, D. L., François, F., & Hamilton, F. A. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2016.36 · Cited by 119
“mortality for right and left sided CRC in comparison with those who have never had a lower endoscopy.(41) There are data to suggest that African Americans have a preference for colonoscopy as a screening choice.”
ResultLan, Z., Yao, X., Sun, K., Li, A., Liu, S., & Wang, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00363 · Cited by 128
“The frequency of recurrence and metastasis in patients with CRC is high, even in patients who have undergone surgical resection, which leads to a poor prognosis of CRC (3).”
BackgroundLiu, L., Tabung, F. K., Zhang, X., Nowak, J. A., Qian, Z. R., Hamada, T., Nevo, D., Bullman, S., Mima, K., Kosumi, K., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.04.030 · Cited by 118
“Information on lifestyles and medication was assessed using biennial questionnaires in both cohorts as previously described.(21,25)”
Self-citationArima, K., Zhong, R., Ugai, T., Zhao, M., Haruki, K., Akimoto, N., Lau, M. C., Okadome, K., Mehta, R. S., Väyrynen, J. P., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.06.054 · Cited by 110
Self-citationColorectal Cancer Screening: Tests, Strategies, and Perspectives
Stracci, F., Zorzi, M., & Grazzini, G. (2014) · Frontiers in Public Health · doi:10.3389/fpubh.2014.00210 · Cited by 123
“Thus, endoscopy tests are likely to confer better individual protection and have a stronger influence on cancer incidence if compared to FIT (17, 102).”
BackgroundHamada, T., Keum, N., Nishihara, R., & Ogino, S. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-016-1272-3 · Cited by 114
Self-citationMiller, E. A., Pinsky, P. F., Schoen, R. E., Prorok, P. C., & Church, T. R. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30358-3 · Cited by 112
Risk Factor Profiles Differ for Cancers of Different Regions of the Colorectum
Wang, L., Lo, C., He, X., Hang, D., Wang, M., Wu, K., Chan, A. T., Ogino, S., Giovannucci, E. L., & Song, M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.03.054 · Cited by 122
Self-citationSpadaccini, M., Albéniz, E., Pohl, H., Maselli, R., Chandrasekar, V. T., Correale, L., Anderloni, A. A., Carrara, S., Fugazza, A., Badalamenti, M., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.03.051 · Cited by 113
Attendance and Yield Over Three Rounds of Population-Based Fecal Immunochemical Test Screening
Kapidzic, A., Grobbee, E. J., Hol, L., van Roon, A. H., van Vuuren, A. J., Spijker, W., Izelaar, K., van Ballegooijen, M., Kuipers, E. J., & van Leerdam, M. E. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.168 · Cited by 112
May, F. P., Yang, L., Corona, E., Glenn, B. A., & Bastani, R. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.09.008 · Cited by 112
Leung, W. K., Lo, O. S. H., Liu, K. S. H., Tong, T., But, D. Y. K., Lam, F. Y. F., Hsu, A. S. J., Wong, S. Y., Walter Seto, W. K., Hung, I. F. N., et al. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.83 · Cited by 111
Morbidity and mortality after surgery for nonmalignant colorectal polyps
Peery, A. F., Shaheen, N. J., Cools, K. S., Baron, T. H., Koruda, M. J., Galanko, J. A., & Grimm, I. S. (2017) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2017.03.1550 · Cited by 111
“Four separate models were fit to capture the more common adverse events: (1) ostomy, (2) reoperation, (3) readmission, and (4) a composite of deep incisional site infections, absce s es, anastomotic leak and wound dehiscence.”
MethodOptimal Strategies for Colorectal Cancer Screening
Jain, S., Maque, J., Galoosian, A., Osuna-Garcia, A., & May, F. P. (2022) · Current Treatment Options in Oncology · doi:10.1007/s11864-022-00962-4 · Cited by 110
High-quality Bowel Preparation Is Required for Detection of Sessile Serrated Polyps
Clark, B. T., & Laine, L. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.03.044 · Cited by 110
Peng, L., Weigl, K., Boakye, D., & Brenner, H. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0209-2 · Cited by 118
Colorectal Cancer Screening, Version 1.2015
Provenzale, D., Jasperson, K. W., Ahnen, D. J., Aslanian, H. R., Bray, T., Cannon, J. A., David, D. S., Early, D. S., Erwin, D. O., Ford, J. M., et al. (2015) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2015.0116 · Cited by 109
CCNA2 acts as a novel biomarker in regulating the growth and apoptosis of colorectal cancer
Gan, Y., Li, Y., Li, T., Shu, G., & Yin, G. (2018) · Cancer Management and Research · doi:10.2147/cmar.s176833 · Cited by 112
Zhao, H., Chen, S., & Fu, Q. (2020) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29600 · Cited by 108
“1–3 Although technological progress in early detection and intervention to a certain degree have improved the overall survival rate of patients with CRC, the prognosis of patients with advanced‐stage CRC remains poor due to recurrence and metastasis after surgery.(4,5) Distant metastasis and drug resistance are accept…”
BackgroundStool DNA Testing for Screening Detection of Colorectal Neoplasia in Alaska Native People
Redwood, D. G., Asay, E. D., Blake, I. D., Sacco, P. E., Christensen, C. M., Sacco, F. D., Tiesinga, J. J., Devens, M. E., Alberts, S. R., Mahoney, D. W., et al. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.10.008 · Cited by 107
Cadoni, S., Falt, P., Rondonotti, E., Radaelli, F., Fojtík, P., Gallittu, P., Liggi, M., Amato, A., Paggi, S., Šmajstrla, V., et al. (2017) · Endoscopy · doi:10.1055/s-0043-101229 · Cited by 109
“First, our study confirms previous observations that water exchange can increase the detection rate of clinically relevant neoplastic lesions [11,16 – 18,21], which is well known to be associated with a higher CRC protection rate [22,23].”
Carr, P. R., Alwers, E., Bienert, S., Weberpals, J. G., Kloor, M., Brenner, H., & Hoffmeister, M. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy059 · Cited by 112
Nagl, S., Ebigbo, A., Goelder, S. K., Römmele, C., Neuhaus, L., Weber, T., Braun, G., Probst, A., Schnoy, E., Kafel, A. J., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.07.044 · Cited by 104
Long-Term Colorectal Cancer Incidence and Mortality After a Single Negative Screening Colonoscopy
Pilonis, N. D., Bugajski, M., Wieszczy, P., Franczyk, R., Didkowska, J., Wojciechowska, U., Pisera, M., Rupinski, M., Regula, J., & Kaminski, M. F. (2020) · Annals of Internal Medicine · doi:10.7326/m19-2477 · Cited by 103
“These findings are of paramount importance, because previous reports have questioned the efficacy of colonoscopy in the proximal colon (6, 7, 15, 24) and of screening sigmoidoscopy in women (25).”
BackgroundResultIssaka, R. B., Chan, A. T., & Gupta, S. N. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.06.033 · Cited by 122
Self-citationQuality Indicators for Colonoscopy
Rex, D. K., Anderson, J. C., Butterly, L. F., Day, L. W., Dominitz, J. A., Kaltenbach, T. R., Ladabaum, U., Levin, T. R., Shaukat, A., Achkar, J., et al. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002972 · Cited by 117
Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection
Bruhm, D. C., Vulpescu, N. A., Foda, Z. H., Phallen, J. A., Scharpf, R. B., & Velculescu, V. E. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00795-x · Cited by 117
“Motivated by subsequent large-scale studies demonstrating benefits of cancer screening for lung cancer 4,5 , colorectal cancer 6,7 , cervical cancer 8 and breast cancer 9,10 , worldwide organizations have supported widespread screening programmes 11 .”
Schoen, R. E., Razzak, A. A., Yu, K. J., Berndt, S. I., Firl, K., Riley, T. L., & Pinsky, P. F. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.055 · Cited by 99
“51), and to subjects with a FH of CRC who did not undergo any prior colonoscopy.(24) However, one cannot derive recommendations for the optimal timing of colonoscopy from these findings without accounting for the number of affected FDRs, the age of the individuals, and the age of onset in the affected relatives.”
DeMicco, M. P., Clayton, L. B., Pilot, J., Epstein, M. S., Bekal, P., DeMicco, M. P., Epstein, M., Hardi, R., Harper, W. L., Henderson, J. B., et al. (2017) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2017.07.047 · Cited by 98
Prevalence and Clinical Features of Sessile Serrated Polyps: A Systematic Review
Meester, R. G. S., van Herk, M. M. A. G. C., Lansdorp-Vogelaar, I., & Ladabaum, U. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.03.025 · Cited by 96
Meester, R. G. S., Doubeni, C. A., Lansdorp‐Vogelaar, I., Jensen, C. D., van der Meulen, M. P., Levin, T. R., Quinn, V. P., Schottinger, J. E., Zauber, A. G., Corley, D. A., et al. (2015) · JAMA · doi:10.1001/jama.2015.6251 · Cited by 101
“constrained by assuming that (1) sensitivity for cancer was 98% across all quintiles; (2) sensitivity for medium to large adenomas varied less than for small adenomas and increased according to a fixed rule from the lowest to the highest quintile (fixed-detection likelihood (sensitivity/ [1−sensitivity]) ratios for ad…”
Biological significance of the CpG island methylator phenotype
Suzuki, H., Yamamoto, E., Maruyama, R., Niinuma, T., & Kai, M. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.007 · Cited by 113
“A recent population study reported that use of colonoscopy and sigmoidoscopy could reduce both the incidence of CRC and its mortality, while cancers diagnosed after 5 years are more likely to have CIMP and MSI, which may reflect the difficulty of detecting SSA/Ps during colonoscopy [90].”
BackgroundIntegration of molecular pathology, epidemiology and social science for global precision medicine
Nishi, A., Milner, D. A., Giovannucci, E. L., Nishihara, R., Tan, A. S. L., Kawachi, I. I., & Ogino, S. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2016.1115346 · Cited by 110
“[166–168] However, its preventive effect may differ according to molecular subtypes of colorectal cancer and may be less effective for colorectal cancer subtype with microsatellite instability (MSI),[167,169] which is associated with high-level CpG island methylator phenotype (CIMP-high).”
BackgroundSelf-citationLeddin, D. J., Lieberman, D. A., Tse, F., Barkun, A. N., Abou-Setta, A. M., Marshall, J. K., Samadder, N. J., Singh, H., Telford, J. J., Tinmouth, J., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.017 · Cited by 107
Sung, J. J. �., Chiu, H., Lieberman, D. A., Kuipers, E. J., Rutter, M. D., Macrae, F., Yeoh, K. G., Ang, T. L., Chong, V. H., John, S., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327377 · Cited by 111
Self-citationSharma, P., Burke, C. A., Johnson, D. A., & Cash, B. D. (2020) · Endoscopy International Open · doi:10.1055/a-1127-3144 · Cited by 105
Tests and investigations for colorectal cancer screening
Carroll, M., Seaman, H. E., & Halloran, S. P. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.04.019 · Cited by 101
Flavonoids and Colorectal Cancer Prevention
Li, Y., Zhang, T., & Chen, G. (2018) · Antioxidants · doi:10.3390/antiox7120187 · Cited by 103
“An effective strategy for reducing colorectal cancer-related mortality is prevention, which includes screening, and indeed, increased screening with colonoscopies has been associated with reduced incidence of colon cancer [2].”
BackgroundDulai, P. S., Singh, S., Marquez, E. O., Khera, R., Prokop, L. J., Limburg, P. J., Gupta, S. N., & Murad, M. H. (2016) · BMJ · doi:10.1136/bmj.i6188 · Cited by 98
Role of Artificial Intelligence in Colonoscopy Detection of Advanced Neoplasias: A Randomized Trial
Mangas-Sanjuan, C., de-Castro, L., Cubiella, J., Díez-Redondo, P., Suárez, A., Pellisé, M., Fernández, N., Zarraquiños, S., Núñez-Rodríguez, H., Álvarez-García, V., et al. (2023) · Annals of Internal Medicine · doi:10.7326/m22-2619 · Cited by 85
Keswani, R. N., Law, R. J., Ciolino, J. D., Lo, A. A., Gluskin, A. B., Bentrem, D. J., Komanduri, S., Pacheco, J. A., Grande, D. P., & Thompson, W. K. (2016) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2016.01.048 · Cited by 89
Takeuchi, Y., Mabe, K., Shimodate, Y., Yoshii, S., Yamada, S., Iwatate, M., Kawamura, T., Hotta, K., Nagaike, K., Ikezawa, N., et al. (2019) · Annals of Internal Medicine · doi:10.7326/m19-0026 · Cited by 95
Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare Systems
Burnett‐Hartman, A. N., Mehta, S. J., Zheng, Y., Ghai, N. R., McLerran, D., Chubak, J., Quinn, V. P., Skinner, C. S., Corley, D. A., Inadomi, J. M., et al. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.02.025 · Cited by 95
Sessile Serrated Adenomas: An Evidence-Based Guide to Management
Crockett, S. D., Snover, D. C., Ahnen, D. J., & Baron, J. A. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.10.035 · Cited by 101
Patel, S. G., Schoenfeld, P., Kim, H. M., Ward, E. K., Bansal, A., Kim, Y., Hosford, L., Myers, A., Foster, S., Craft, J., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.10.042 · Cited by 87
“The secondary aims for the in-vivo phase included (1) evaluating overall group performance of optical diagnoses using NBI by degree of confidence and by location within the colon, (2) evaluating individual performance on the ASGE PIVI benchmarks, (3) determining predictors of performance and (4) determining real-time…”
Screening for Colorectal Cancer
Patel, S. G., & Dominitz, J. A. (2024) · Annals of Internal Medicine · doi:10.7326/aitc202404160 · Cited by 110
Sung, J. J. �., Wong, M. C. S., Lam, T. Y. T., Tsoi, K. K. F., Chan, V. C. W., Cheung, W. W. L., & Ching, J. Y. L. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13835 · Cited by 88
Aspects of colorectal cancer screening, methods, age and gender
Hultcrantz, R. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13171 · Cited by 98
Different risk factors for advanced colorectal neoplasm in young adults
Kim, J. Y., Jung, Y. S., Park, J. H., Kim, H. J., Cho, Y. K., Sohn, C. I., Jeon, W. K., Kim, B. I., Choi, K. Y., & Park, D. I. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i13.3611 · Cited by 84
Kawamura, T., Wada, H., Sakiyama, N., Ueda, Y., Shirakawa, A., Okada, Y., Sanada, K., Nakase, K., Mandai, K., Suzuki, A., et al. (2017) · Digestive Endoscopy · doi:10.1111/den.12804 · Cited by 84
Efficacy of Per-oral Methylene Blue Formulation for Screening Colonoscopy
Repici, A., Wallace, M. B., East, J. E., Sharma, P., Ramirez, F. C., Bruining, D. H., Young, M., Gatof, D., Irene (Mimi) Canto, M., Marcon, N., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.02.001 · Cited by 84
Liu, L., Nishihara, R., Qian, Z. R., Tabung, F. K., Nevo, D., Zhang, X., Song, M., Cao, Y., Mima, K., Masugi, Y., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.08.045 · Cited by 83
Self-citationKosumi, K., Hamada, T., Koh, H., Borowsky, J., Bullman, S., Twombly, T. S., Nevo, D., Masugi, Y., Liu, L., da Silva, A., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.08.015 · Cited by 91
Self-citationLong-term Risk of Colorectal Cancer and Related Deaths After a Colonoscopy With Normal Findings
Lee, J. K., Jensen, C. D., Levin, T. R., Zauber, A. G., Schottinger, J. E., Quinn, V. P., Udaltsova, N., Zhao, W. K., Fireman, B. H., Quesenberry, C. P., et al. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.5565 · Cited by 82
Zhang, J., Chen, G., Li, Z., Zhang, P., Li, X., Gan, D., Cao, X., Du, H., Zhang, J., Zhang, L., et al. (2020) · Journal of Cancer · doi:10.7150/jca.46661 · Cited by 96
“Finally, twenty-nine articles [8, 10, 11, 24, 25, 27, 35-57] were enrolled for metaanalysis.”
BackgroundResultInfluentialGuo, F., Chen, C., Holleczek, B., Schöttker, B., Hoffmeister, M., & Brenner, H. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001146 · Cited by 85
“, at recruitment only (15,16), or focused on specific professional groups (such as female teachers or health care professionals) or age groups only (17–19) and on CRC incidence (19) or mortality only (18).”
BackgroundResultColorectal cancer screening from 45 years of age: Thesis, antithesis and synthesis
Mannucci, A., Zuppardo, R. A., Rosati, R., Leo, M. D., Perea, J., & Cavestro, G. M. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i21.2565 · Cited by 95
Screening for Colorectal Cancer and Evolving Issues for Physicians and Patients
Lieberman, D. A., Ladabaum, U., Cruz–Correa, M., Ginsburg, C. H., Inadomi, J. M., Kim, L. S., Giardiello, F. M., & Wender, R. C. (2016) · JAMA · doi:10.1001/jama.2016.17418 · Cited by 82
Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening
Vlugt, M. V., Grobbee, E. J., Bossuyt, P. M., Bongers, E., Spijker, W., Kuipers, E. J., Lansdorp‐Vogelaar, I., Essink‐Bot, M., Spaander, M. C. W., & Dekker, E. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.399 · Cited by 82
“A high rate of consistent participation increases the program sensitivity of FIT screening (Winawer et al, 1993; Launoy et al, 1998; Zauber et al, 2012; Nishihara et al, 2013).”
BackgroundCancer Screening Patterns Among Current, Former, and Never Smokers in the United States, 2010-2015
Sanford, N. N., Sher, D. J., Butler, S. S., Xu, X., Ahn, C. W., D'Amico, A. V., Rebbeck, T. R., Aizer, A. A., & Mahal, B. A. V. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.3759 · Cited by 82
Troeung, L., Sodhi‐Berry, N., Martini, A., Malacova, E., Ee, H. C., O'Leary, P. C., Lansdorp‐Vogelaar, I., & Preen, D. B. (2017) · Frontiers in Public Health · doi:10.3389/fpubh.2017.00179 · Cited by 92
Qaseem, A., Harrod, C. S., Crandall, C. J., Wilt, T. J., Wilt, T. J., Crandall, C. J., Balk, E. M., Cooney, T. G., Cross, J. T., Fitterman, N., et al. (2023) · Annals of Internal Medicine · doi:10.7326/m23-0779 · Cited by 88
“Both NRSs found colonoscopy reduced CRC incidence, but neither evaluated all-causemortality (22, 23).”
BackgroundLi, M., Cao, S., & Xu, R. (2025) · 癌症:英文版 · doi:10.1002/cac2.70017 · Cited by 92
“There is sound proof that screening, either by lower endoscopy or fecal occult blood test, can reduce both the incidence and mortality of colorectal cancer [9, 40, 41].”
Colorectal cancer statistics, 2026
Siegel, R. L., Wagle, N. S., Star, J., Kratzer, T. B., Smith, R. A., & Jemal, A. (2026) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.70067 · Cited by 213
Freeman, H. J. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i46.8468 · Cited by 94
Kim, H. G., Thosani, N. C., Banerjee, S., Chen, A. M., & Friedland, S. (2014) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2014.08.038 · Cited by 79
Ma, C., Teriaky, A., Sheh, S., Forbes, N., Heitman, S. J., Jue, T. L., Munroe, C. A., Jairath, V., Corley, D. A., & Lee, J. K. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000407 · Cited by 81
Yamaguchi, D., Shimoda, R., Miyahara, K., Yukimoto, T., Sakata, Y., Takamori, A., Mizuta, Y., Fujimura, Y., Inoue, S., Tomonaga, M., et al. (2024) · Digestive Endoscopy · doi:10.1111/den.14573 · Cited by 78
Fecal DNA Testing for Colorectal Cancer Screening
Carethers, J. M. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-103018-123125 · Cited by 81
Protein and glycomic plasma markers for early detection of adenoma and colon cancer
Rho, J.-H., Ladd, J. J., Li, C. I., Potter, J. D., Zhang, Y., Shelley, D., Shibata, D., Coppola, D., Yamada, H., Toyoda, H., et al. (2016) · Gut · doi:10.1136/gutjnl-2016-312794 · Cited by 83
Colorectal cancer screening of the general population in East Asia
Sano, Y., Byeon, J., Li, X., Wong, M. C. S., Chiu, H., Rerknimitr, R., Utsumi, T., Hattori, S., Sano, W., Iwatate, M., et al. (2015) · Digestive Endoscopy · doi:10.1111/den.12579 · Cited by 85
Fedewa, S. A., Flanders, W. D., Ward, K. C., Lin, C. C., Jemal, A., Sauer, A. G., Doubeni, C. A., & Goodman, M. G. (2017) · Annals of Internal Medicine · doi:10.7326/m16-1154 · Cited by 77
Metadata
- Authors
- Nishihara, R., Wu, K., Lochhead, P., Morikawa, T., Liao, X., Qian, Z. R., Inamura, K., Kim, S. A., Kuchiba, A., Yamauchi, M., Imamura, Y., Willett, W. C., Rosner, B. A., Fuchs, C. S., Giovannucci, E., Ogino, S., & Chan, A. T.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- National Institutes of Health (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-09-19
- Volume
- 369
- Issue
- 12
- Pages
- 1095-1105
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC3840160
- OpenAlex
- W2143929290
- Semantic Scholar
- 778a578187bee44d1da1af275742817bc03017d3
- Cited by
- 1,483
- References
- 44
- Citations by year
- 2026: 42 · 2025: 77 · 2024: 105 · 2023: 102 · 2022: 108 · 2021: 144 · 2020: 139 · 2019: 118 · 2018: 121 · 2017: 124 · 2016: 140 · 2015: 141 · 2014: 102 · 2013: 12
- FWCI
- 70.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Funders
- National Cancer Institute (P50CA127003, R01CA151993, R01CA137178, P01CA087969, P01CA055075, UM1CA167552)
- National Institute of Diabetes and Digestive and Kidney Diseases (K24DK098311, P30DK043351)
- Topics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- colorectal cancer, colonoscopy, sigmoidoscopy, colorectal cancer screening, right-sided colon cancer, cancer incidence, cancer mortality, polypectomy, CpG island methylator phenotype, microsatellite instability, Lynch syndrome, Nurses' Health Study, Health Professionals Follow-up Study, timing of endoscopy, DNA methylation, tumor suppressor
- MeSH terms
- Adenoma, Aged, Colonic Polyps, Colonoscopy, DNA, Neoplasm, Female, Humans, Male, Middle Aged, Mutation, Sigmoidoscopy, United States, Colorectal Neoplasms, Cohort Studies, Incidence, Multivariate Analysis, Microsatellite Instability, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.